Changes in walking distance after epidural steroid injection in patients with lumbar spinal stenosis: a randomized controlled trial comparing caudal and transforaminal techniques

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20250911004

Enrollment

108

Registered

2025-09-11

Start date

2024-09-26

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal canal stenosis with walking impairment Epidural steroid injection, walking distance

Interventions

Patient was treated by Triamcinolone 80mg + 0.5%Bupivacane hydrochloride 1mL + NSS 7mL via caudal epidural steroid injection route,Patient was treated by Triamcinolone 80mg + 0.5%Bupivacane hydrochlor

Experimental Procedure/Surgery,Active Comparator Procedure/Surgery

Caudal epidural steroid injection,Transforaminal epidural steroid injection

Eligibility

Sex/Gender

All

Age

50 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Spinal canal stenosis confirmed diagnosis via MRI 2. Failed conservative treatment

Exclusion criteria

Exclusion criteria: 1. History of previous epidural steroid injection or spinal surgery 2. Drug allergy 3. Coagulopathy 4. Not well-cooperated

Design outcomes

Primary

Measure	Time frame
Walking distance At 2 and 6 weeks after treatment Walking distance in meters	—

Secondary

Measure	Time frame
Pain score At 2 and 6 weeks after treatment Visual analog scale,Disability At 2 and 6 weeks after treatment ODI score	—

Countries

Thailand

Contacts

Public ContactWinatchapol Pumpitakkul

Chonburi hospital

winatchapol@gmail.com038931000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026